Sign in to continue:

Friday, April 10th, 2026

Coursera, Inc. Approves Merger with Udemy and Increases Authorized Shares to 600 Million

Coursera, Inc. Announces Shareholder Approval for Merger with Udemy and Authorized Share Increase

Key Highlights:

  • Shareholders of Coursera, Inc. have approved the proposed business combination (merger) with rival online learning platform Udemy.
  • Shareholders also voted to amend Coursera’s Amended and Restated Certificate of Incorporation, doubling the number of authorized common shares from 300 million to 600 million.
  • The merger remains subject to final closing conditions as outlined in the Merger Agreement.

1. Merger with Udemy Approved

At a special meeting, Coursera, Inc. shareholders voted in favor of the proposed business combination transaction with Udemy. This merger will combine two of the largest players in the online education sector, potentially creating a global leader in online learning and skilling solutions. The closing of the merger is subject to the satisfaction of remaining conditions as set forth in the Merger Agreement.

2. Authorized Share Increase

Shareholders overwhelmingly approved an amendment to Coursera’s Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 600,000,000. This action likely supports the issuance of shares needed for the merger and may provide additional flexibility for future capital raises or strategic initiatives.

3. Voting Results

Proposal 1 (Merger Approval):

  • For: 112,318,586
  • Against: 273,944
  • Abstain: 359,586
  • Broker Non-Votes: 0

Proposal 2 (Authorized Share Increase):

  • For: 111,016,381
  • Against: 1,581,645
  • Abstain: 354,090
  • Broker Non-Votes: 0

4. Implications for Shareholders and Market Impact

These developments are highly significant and potentially price-sensitive:

  • Merger Synergies: The combination of Coursera and Udemy is expected to accelerate growth, expand market reach, and enable the companies to leverage complementary strengths in AI innovation and learning solutions. Investors should monitor for further details on synergy realization, cost structures, and integration plans.
  • Authorized Shares Increase: Doubling the authorized share count gives the combined entity the ability to issue new shares for the merger, future M&A, fund-raising, or employee compensation. While this provides flexibility, it may also introduce potential dilution concerns for existing shareholders.
  • Market Leadership: The new entity is poised to become a dominant force in the online learning sector, which may attract increased investor attention, but also scrutiny from competitors and regulators.

5. Risks and Forward-Looking Statements

The report includes a comprehensive “Cautionary Note Regarding Forward-Looking Statements.” It highlights that the transaction’s anticipated benefits—such as growth acceleration, synergies, and value creation—are subject to substantial risks and uncertainties. These include:

  • General economic, market, and competitive conditions
  • Risks related to the online learning sector and AI innovations
  • Potential business disruptions post-merger
  • Ability to achieve expected synergies and operational integration
  • Fluctuations in share price of both Coursera and Udemy
  • Costs associated with the transaction

Shareholders are encouraged to review the detailed risk factors included in the Proxy Statement and other SEC filings.

6. Management and Filings

The Form 8-K was signed by Alan B. Cardenas, Senior Vice President, General Counsel, and Secretary of Coursera, Inc. The company is listed on the NYSE under the ticker symbol “COUR.”


Disclaimer: This article is for informational purposes only and does not constitute investment advice. The forward-looking statements discussed herein are subject to risks and uncertainties that could cause actual results to differ materially. Investors should review official filings and consult with financial advisors before making investment decisions.

View Coursera, Inc. Historical chart here



Bank First Corp 2025 Annual 10-K Report: Financial Instrument Portfolio Segments and Credit Assessment Overview

Bank First Corp 2025 10-K: Key Takeaways for Investors ...

Apyx Medical Corporation 2025 Annual Report: Innovation in Surgical Aesthetics, AYON Launch, and Global Expansion

Apyx Medical Corporation 2025 Annual Report – Key Investor H...

   Ad